The Hip Reconstruction application encompasses all surgical interventions aimed at restoring hip joint function, primarily total hip arthroplasty (THA), partial hip arthroplasty (PHA), and revision hip procedures. THA accounts for the majority of procedures, driven by aging demographics and rising osteoarthritis prevalence; it contributes roughly 30 % of total market revenue. PHA, typically indicated for femoral head‑preserving cases, adds an estimated 8 % share, reflecting its niche but growing role in younger patient cohorts. Revision hip surgery, which addresses implant failure or infection, represents about 7 % of the market, with higher unit prices offsetting its lower volume. Collectively, these sub‑categories generate close to 45 % of the overall hips knees reconstructive market, underscoring the centrality of hip‑focused technologies and implants in the market taxonomy. The segment’s growth is further supported by advances in implant materials, minimally invasive techniques, and expanding reimbursement frameworks. Geographically, North America and Europe together account for roughly two‑thirds of hip‑related spend, while emerging markets in Asia‑Pacific are projected to increase their share as surgical capacity expands.
